Aiping Zhou

6PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 30, 2025
Serum BDNF helps identify favorable subgroups in HCC patients treated with PD-L1 inhibitors and anti-angiogenic TKIs.

Caifeng Gong, Jinglong Huang, Dandan Cao

|Mar 08, 2024
Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial.

Zhichao Jiang, Yibin Xie, Wen Zhang

|Jun 22, 2022
DLGAP1-AS2-Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma.

Yabing Nan, Qingyu Luo, Xiaowei Wu

|Apr 07, 2021
Anlotinib in the treatment of advanced hepatocellular carcinoma: an open-label phase II study (ALTER-0802 study).

Yongkun Sun, Aiping Zhou, Wen Zhang

|Jul 29, 2018
Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trial.

Wen Zhang, Chunxia Du, Yongkun Sun

|Aug 29, 2017
Efficacy of Topical Compound Danxiong Granules for Treatment of Dermatologic Toxicities Induced by Targeted Anticancer Therapy: A Randomized, Double-Blind, Placebo-Controlled Trial.

Aiping Tian, Aiping Zhou, Xinyu Bi

Pageof 1

Frequent Collaborators

1 joint publications

Aiping Tian

1 joint publications

Shangying Hu

1 joint publications

Zhichao Jiang

1 joint publications

Zhen Huang